Pricing Log in Create free account

Adlai Nortye Ltd. Sponsored ADR (ANL) vs Indaptus Therapeutics, Inc. (INDP)

Adlai Nortye Ltd. Sponsored ADR and Indaptus Therapeutics, Inc. are both Biotechnology companies. Adlai Nortye Ltd. Sponsored ADR is the larger, with a market value of $562.6M against $497.6M — 1.1× the size. Across the 7 metrics below, Adlai Nortye Ltd. Sponsored ADR leads on 4 and Indaptus Therapeutics, Inc. on 3.

Valuation

Metric ANL INDP Biotechnology median
P/E — n/m 10.64
P/S — n/m 9.59
P/B n/m 33.39 2.15
Price to free cash flow n/m n/m 26.07
EV/EBITDA n/m n/m 0.65
EV/Sales n/m n/m 9.45
Earnings yield — (236.87%) (34.69%)
Free cash flow yield 0.00% (3.87%) (24.02%)

Profitability

Metric ANL INDP Biotechnology median
Gross margin — 0.00% 65.59%
Operating margin — 0.00% 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (318.04%) (51.96%)
Return on assets 0.00% (163.84%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANL INDP Biotechnology median
Revenue growth (TTM) — — 4.59%
EPS growth (last fiscal year) 31.48% 52.15% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ANL INDP Biotechnology median
Debt to equity 0.12 0.00 0.00
Current ratio 9.55 19.48 4.86
Net debt to EBITDA (0.05) 0.43 1.01

Dividend

Metric ANL INDP Biotechnology median
Dividend yield — — 0.38%
Payout ratio — — —

Size

Metric ANL INDP Biotechnology median
Market cap 562.63m 497.60m 174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack